Substance / Medication

Nadroparin

Overview

Active Ingredient
nadroparin
RxNorm CUI
67031

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

8 trials linked to this intervention

8
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis.
Ageno Walter, Bosch Jacqueline, Cucherat Michel et al. · J Thromb Thrombolysis · 2016
PMID: 26497987Meta-Analysis
Influence of Fondaparinux Versus Nadroparin Calcium Thromboprophylaxis on Clinical Parameters Following Total Knee Arthroplasty
Mihaljević Zdravka, Dimnjaković Damjan, Tripković Branko et al. · Acta Clin Croat · 2016
PMID: 29045105RCT
Subcutaneous nadroparin calcium in the treatment of recent onset retinal vein occlusion: a pilot study.
Pinna Antonio, Simula Piera, Zinellu Angelo · J Ocul Pharmacol Ther · 2012
PMID: 22519543RCT
Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromes.
Yan Hong-bing, Song Li, Liu Ran et al. · Chin Med J (Engl) · 2011
PMID: 21518596RCT
The effect of LMWH (Nadroparin) on tumor progression.
Nagy Zsuzsanna, Turcsik Vera, Blaskó György · Pathol Oncol Res · 2009
PMID: 19757196RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Nadroparin (substance)
SNOMED CT
699946002
UMLS CUI
C0206232
RxNorm CUI
67031

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

6
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
8
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.